Monopar Therapeutics (MNPR) Misses Q1 EPS by 46c
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Join SI Premium – FREE
Monopar Therapeutics (NASDAQ: MNPR) reported Q1 EPS of ($0.46).
For earnings history and earnings-related data on Monopar Therapeutics (MNPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- TORM plc (TRMD) Misses Q2 EPS by 5c; updates guidance
- UBS Upgrades SolarEdge (SEDG) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
